上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1380Please respect copyright.PENANABpjjHG0EUC
1380Please respect copyright.PENANAjnqMRQBt6g
上集:https://www.penana.com/article/4711251380Please respect copyright.PENANAaw3OcwNixo
1380Please respect copyright.PENANAEg6wrIH7yP1380Please respect copyright.PENANAh890ipEljZ
1380Please respect copyright.PENANAF1DsQvG62Q
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1380Please respect copyright.PENANAGUbMwBADI3
1380Please respect copyright.PENANABPS2paToEh
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1380Please respect copyright.PENANAs1y1bDNw4I
1380Please respect copyright.PENANASX3LqE3Z0j
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1380Please respect copyright.PENANAnubOAze12Q
1380Please respect copyright.PENANAOVusJQb2TG1380Please respect copyright.PENANAi3FNqLZ6qH
1380Please respect copyright.PENANAibAwHp9uXz
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1380Please respect copyright.PENANAzvM8vzUeTL
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1380Please respect copyright.PENANANtxkaTBIPN
1380Please respect copyright.PENANAP65fP4w6mY
忘記甚麼是Neoantigen的話,可重溫上一集。1380Please respect copyright.PENANAtezz5kD0Mi
1380Please respect copyright.PENANAhVG9hV4Sa0
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1380Please respect copyright.PENANAX34kF4gflX
1380Please respect copyright.PENANALawYKGuceI
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1380Please respect copyright.PENANA17YZUZapIo
1380Please respect copyright.PENANA1K052lF8301380Please respect copyright.PENANAbZaRoAy0rd
1380Please respect copyright.PENANAJtt2wQTtf2
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1380Please respect copyright.PENANAHtAcSeMq5Z
1380Please respect copyright.PENANAzAp06vDole
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1380Please respect copyright.PENANAjMdf9CDrG6
1380Please respect copyright.PENANA30V80Ezj6q
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1380Please respect copyright.PENANAoN85dbwDcB1380Please respect copyright.PENANABOS1xKQ7wG
1380Please respect copyright.PENANAGE8mif6eDk
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1380Please respect copyright.PENANAoTJZNyIvKB
1380Please respect copyright.PENANAQ6qgPMwIjo
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1380Please respect copyright.PENANAVvYA4HfrMV1380Please respect copyright.PENANADHc4bSW7PT
1380Please respect copyright.PENANAXfhM0ZWwJb
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1380Please respect copyright.PENANA6GRgt9vQHm
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1380Please respect copyright.PENANAgxFrQNdrfh
1380Please respect copyright.PENANAekTydK4nMo
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1380Please respect copyright.PENANATVUaOu4uOS
1380Please respect copyright.PENANARIkQGfy1yI
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1380Please respect copyright.PENANA60rHdKscn1
1380Please respect copyright.PENANATJ9w7FCm3c
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1380Please respect copyright.PENANAjan1ESgSV4
1380Please respect copyright.PENANA2xPq0TnsKt
1380Please respect copyright.PENANA73fuC1sigo
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1380Please respect copyright.PENANAGa3tgYdzaJ
1380Please respect copyright.PENANAUEptPujRhm
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1380Please respect copyright.PENANAJwUnY6KBvz
1380Please respect copyright.PENANAHyr1biuiDR
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1380Please respect copyright.PENANARmLSG99yRl
1380Please respect copyright.PENANA3JyU3IxHsr
Link:1380Please respect copyright.PENANA31P0bkI80e
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1380Please respect copyright.PENANACVAL3YU2mq
1380Please respect copyright.PENANACTOzxxEdUy
1380Please respect copyright.PENANALM3SUVREBO
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1380Please respect copyright.PENANA7r2rKZxJUg